DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
3••• L••••••••• L•••• U••••• S••••• o• A•••••• I••••• I••
Pharmaceuticals & Life Sciences Rate P+8.50%, 1.00% Floor (0.50% on unfunded)group grade Aoff every schedule since Dec 31, 2025sponsor unattributed
Nothing material in the last 200 days. Last change: 31 Dec 2025, $17M principal held by 1 lender; matures Nov 2026.
Principal held
at least $17.0M
sum of BDC pieces, a lower bound
Fair value
$13.9M
87c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Nov 5, 2026
$17.0M inside 24 months
On the tape since
Dec 31, 2025
latest Dec 31, 2025
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| S••••• P•••• S•••••••• L•••••• F••• | $17M | 86¢ | new this quarter |
Every BDC piece · 2 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| S••••• P•••• S•••••••• L•••••• F••• | term loan first lien I••••••••• 1st L••• T••• L••• I••••••• P••••••••• & L••• S••••••• R••• S+6.86%, 1.00% F••• | $15.7M | $13.4M 86c | SOFR+686 bp |
| S••••• P•••• S•••••••• L•••••• F••• | revolver first lien I••••••••• 1st L••• R••••••• I••••••• P••••••••• & L••• S••••••• R••• P+8.50%, 1.00% F•••• | $1.2M | $584,869 123c | Prime+850 bp |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Dec 31, 2025 | at least $15.7M | 86c | SOFR+686 bp | Nov 5, 2026 | 1 |
| first lien revolver first lien exited Dec 31, 2025 | at least $1.2M | 123c | Prime+850 bp | Nov 5, 2026 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | $17.0M | $13.9M | 87c | 0 |
What changed
- New borrower on a BDC scheduleDec 31, 2025
- Facility left every BDC scheduleDec 31, 2025
- Facility left every BDC scheduleDec 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- 31ST LIEN SECURED LOANS UNITED STATES OF AMERICA INOTIVderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticals & Life Sciences Rate P+8.50%, 1.00% Floor (0.50% on unfunded)reportedas one filer wrote it